Cracking the diversity of sweet drugs

Sharon Yehuda, Vered Padler-Karavani*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug.

Original languageEnglish
Pages (from-to)1397-1398
Number of pages2
JournalNature Chemical Biology
Volume20
Issue number11
DOIs
StatePublished - Nov 2024

Fingerprint

Dive into the research topics of 'Cracking the diversity of sweet drugs'. Together they form a unique fingerprint.

Cite this